{
  "actions": [
    {
      "acted_at": "2005-11-16", 
      "references": [
        {
          "reference": "CR S12958-12959", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2005-11-16", 
      "committee": "Committee on Finance", 
      "references": [
        {
          "reference": "CR S12959", 
          "type": "text of measure as introduced"
        }
      ], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Finance.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s2026-109", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Finance", 
      "committee_id": "SSFI"
    }
  ], 
  "congress": "109", 
  "cosponsors": [
    {
      "district": null, 
      "name": "Dayton, Mark", 
      "sponsored_at": "2005-11-16", 
      "state": "MN", 
      "thomas_id": "01629", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Dorgan, Byron L.", 
      "sponsored_at": "2005-11-16", 
      "state": "ND", 
      "thomas_id": "00308", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Kerry, John F.", 
      "sponsored_at": "2005-11-16", 
      "state": "MA", 
      "thomas_id": "01379", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2005-11-16", 
  "number": "2026", 
  "official_title": "A bill to amend title XVIII of the Social Security Act to require that a prescription drug plan or an MA-PD plan that has an initial coverage limit obtain a signed certification prior to enrolling benficiaries under the plan under part D of such title.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Medicare Prescription Drug Gap Disclosure Act", 
  "sponsor": {
    "district": null, 
    "name": "Lautenberg, Frank R.", 
    "state": "NJ", 
    "thomas_id": "01381", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2005-11-16", 
  "subjects": [
    "Drugs", 
    "Finance and financial sector", 
    "Health", 
    "Insurance premiums", 
    "Medicare", 
    "Prescription pricing", 
    "Social welfare"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2005-11-16", 
    "text": "Medicare Prescription Drug Gap Disclosure Act - Amends title XVIII (Medicare) of the Social Security Act to require that a prescription drug plan or a Medicare Advantage Prescription Drug Plan with an initial coverage limit obtain a signed certification by an enrollee (or legal guardian), before enrolling, that acknowledges that: (1) a gap in coverage during a given year might occur; and (2) the enrollee, in such a case, will be responsible for paying 100% of the cost of his or her prescription drugs, in addition to the plan's monthly premium."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Medicare Prescription Drug Gap Disclosure Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to amend title XVIII of the Social Security Act to require that a prescription drug plan or an MA-PD plan that has an initial coverage limit obtain a signed certification prior to enrolling benficiaries under the plan under part D of such title.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:37:54-05:00"
}